Reviewed,
UniProtKB/Swiss-Prot O15120 (PLCB_HUMAN)
Last modified
July 22, 2008.
Version 76.
History...
Clusters with 100%,
90%,
50% identity |
Documents (7) |
Third-party data |
Customize display | text xml rdf/xml gff fasta |
Names and origin
| Protein names | Recommended name: 1-acyl-sn-glycerol-3-phosphate acyltransferase beta EC=2.3.1.51 Alternative name(s): 1-AGP acyltransferase 2 Short name(s)=1-AGPAT 2 Lysophosphatidic acid acyltransferase beta Short name(s)=LPAAT-beta 1-acylglycerol-3-phosphate O-acyltransferase 2 | ||
| Gene names |
| ||
| Organism | Homo sapiens (Human) | ||
| Taxonomic identifier | 9606 [NCBI] | ||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
Protein attributes
| Sequence length | 278 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is not processed. |
| Protein existence | Evidence at protein level. |
General annotation (Comments)
| Function | Converts lysophosphatidic acid (LPA) into phosphatidic acid by incorporating an acyl moiety at the sn-2 position of the glycerol backbone. |
| Catalytic activity | Acyl-CoA + 1-acyl-sn-glycerol 3-phosphate = CoA + 1,2-diacyl-sn-glycerol 3-phosphate. |
| Pathway | |
| Subcellular location | Membrane; Multi-pass membrane proteinPotential. |
| Tissue specificity | Expressed predominantly in heart and liver. |
| Domain | The HXXXXD motif is essential for acyltransferase activity and may constitute the binding site for the phosphate moiety of the glycerol-3-phosphate By similarity. |
| Involvement in disease | Defects in AGPAT2 are the cause of congenital generalized lipodystrophy type 1 (CGL1) [MIM:608594]; also known as Berardinelli-Seip congenital lipodystrophy type 1 (BSCL1) or Berardinelli-Seip syndrome. CGL1 is an autosomal recessive disorder characterized by marked paucity of adipose tissue, extreme insulin resistance, hypertriglyceridemia, hepatic steatosis and early onset of diabetes. |
| Sequence similarities | Belongs to the 1-acyl-sn-glycerol-3-phosphate acyltransferase family. |
Ontologies
Keywords | |
|---|---|
| Biological process | Phospholipid biosynthesis |
| Cellular component | Membrane |
| Coding sequence diversity | Alternative splicing |
| Disease | Disease mutation |
| Domain | Transmembrane |
| Molecular function | Acyltransferase Transferase |
| PTM | Phosphoprotein |
Gene Ontology (GO) | |
| Biological process | phosphatidic acid biosynthetic process Ref.3 Traceable author statement. Source: ProtInc |
| Cellular component | cytosol Ref.1 Inferred from Experiment. Source: Reactome endoplasmic reticulumInferred from sequence or structural similarity. Source: UniProtKB |
| Molecular function | 1-acylglycerol-3-phosphate O-acyltransferase activity Non-traceable author statement. Source: UniProtKB phospholipid:diacylglycerol acyltransferase activity Ref.1Inferred from Experiment. Source: Reactome |
| Complete GO annotation... | |
Alternative products
| This entry describes 2 isoforms produced by alternative splicing. [Align] [Select] | |||||
| Isoform 1 (identifier: O15120-1) This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | |||||
| Isoform 2 (identifier: O15120-2) The sequence of this isoform differs from the canonical sequence as follows: 165-196: Missing. | |||||
| Notes: No experimental confirmation available. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | ||||
Molecule processing | ||||||||
|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 278 | 278 | 1-acyl-sn-glycerol-3-phosphate acyltransferase beta | |||||
Regions | ||||||||
| Transmembrane | 1 – 21 | 21 | Potential | |||||
| Transmembrane | 30 – 50 | 21 | Potential | |||||
| Transmembrane | 122 – 142 | 21 | Potential | |||||
| Motif | 98 – 103 | 6 | HXXXXD motif | |||||
Amino acid modifications | ||||||||
| Modified residue | 255 | 1 | Phosphothreonine By similarity | |||||
| Modified residue | 260 | 1 | Phosphoserine By similarity | |||||
Natural variations | ||||||||
| Alternative sequence | 165 – 196 | 32 | Missing in isoform 2. | |||||
| Natural variant | 136 | 1 | G → R in CGL1. | |||||
| Natural variant | 140 | 1 | Missing in CGL1. | |||||
| Natural variant | 228 | 1 | L → P in CGL1. | |||||
| Natural variant | 239 | 1 | A → V in CGL1. | |||||
Experimental info | ||||||||
| Sequence conflict | 126 | 1 | L → V in AAB64299. Ref.2 | |||||
| Sequence conflict | 200 | 1 | V → F in AAH00026. Ref.5 | |||||
Sequences
| ||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Human lysophosphatidic acid acyltransferase. cDNA cloning, expression, and localization to chromosome 9q34.3." Eberhardt C., Gray P.W., Tjoelker L.W. J. Biol. Chem. 272:20299-20305(1997) [PubMed: 9242711] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1). |
| [2] | "A human cDNA sequence with homology to non-mammalian lysophosphatidic acid acyltransferases." Stamps A.C., Elmore M.A., Hill M.E., Kelly K., Makda A.A., Finnen M.J. Biochem. J. 326:455-461(1997) [PubMed: 9291118] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1). |
| [3] | "Cloning and expression of two human lysophosphatidic acid acyltransferase cDNAs that enhance cytokine-induced signaling responses in cells." West J., Tompkins C.K., Balantac N., Nudelman E., Meengs B., White T., Bursten S., Coleman J., Kumar A., Singer J.W., Leung D.W. DNA Cell Biol. 16:691-701(1997) [PubMed: 9212163] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1). |
| [4] | Leung D.W., Tompkin C.K., West J. Submitted (MAY-2001) to the EMBL/GenBank/DDBJ databases Cited for: SEQUENCE REVISION TO 51. |
| [5] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2). Tissue: Kidney and Skin. |
| [6] | "Acquired and inherited lipodystrophies." Garg A. N. Engl. J. Med. 350:1220-1234(2004) [PubMed: 15028826] [Abstract] Cited for: REVIEW. |
| [7] | "AGPAT2 is mutated in congenital generalized lipodystrophy linked to chromosome 9q34." Agarwal A.K., Arioglu E., de Almeida S., Akkoc N., Taylor S.I., Bowcock A.M., Barnes R.I., Garg A. Nat. Genet. 31:21-23(2002) [PubMed: 11967537] [Abstract] Cited for: VARIANTS CGL1 ARG-136; PHE-140 DEL; PRO-228 AND VAL-239. |
Cross-references
Sequence databases | |
|---|---|
| AF000237 mRNA. Translation: AAC51649.1. AF011374 mRNA. Translation: AAB64299.1. U56418 mRNA. Translation: AAB58776.2. BC000026 mRNA. Translation: AAH00026.1. BC004529 mRNA. Translation: AAH04529.1. | |
| RefSeq | NP_001012745.1. NP_006403.2. |
| UniGene | Hs.320151 |
3D structure databases | |
| ModBase | Search... |
PTM databases | |
| PhosphoSite | O15120. |
Genome annotation databases | |
| Ensembl | ENSG00000169692. Homo sapiens. [Contig view] |
| GeneID | 10555. |
| KEGG | hsa:10555. |
Organism-specific databases | |
| H-InvDB | HIX0008552. |
| HGNC | HGNC:325. AGPAT2. |
| MIM | 603100. gene. 608594. phenotype. |
| Orphanet | 528. Lipodystrophy, Berardinelli type. |
| PharmGKB | PA24622. |
| GenAtlas | Search... |
| GeneCards | Search... |
| GeneLynx | Search... |
Phylogenomic databases | |
| HOVERGEN | O15120. |
Enzyme and pathway databases | |
| Reactome | REACT_602. Lipid and lipoprotein metabolism. |
Gene expression databases | |
| CleanEx | HS_AGPAT2. |
| GermOnline | ENSG00000169692. Homo sapiens. |
Family and domain databases | |
| InterPro | IPR002123. Acyltransferase. IPR004552. AGP_acyltrans. [Graphical view] |
| Pfam | PF01553. Acyltransferase. 1 hit. [Graphical view] |
| SMART | SM00563. PlsC. 1 hit. [Graphical view] |
| TIGRFAMs | TIGR00530. AGP_acyltrn. 1 hit. |
| ProDom | O15120. [Graphical view] [Entries sharing at least one domain] |
| BLOCKS | Search... |
Other Resources | |
| SOURCE | Search... |
| ProtoNet | Search... |
Entry information
| Entry name | PLCB_HUMAN | ||||||||
| Accession | Primary (citable) accession number: O15120 Secondary accession number(s): O00516 Q9BWR7 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation project | HPI (Human Proteome Initiative) | ||||||||
Relevant documents
| Human chromosome 9 Human chromosome 9: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PATHWAY comments Index of metabolic and biosynthesis pathways |
| UniProtKB secondary accession numbers Index of UniProtKB secondary accession numbers |
| SIMILARITY comments Index of protein domains and families |

Clusters with


